Disparities in Recommendations for Colorectal Cancer Screening Among Average-Risk Individuals: An Ecobiosocial Approach

Overview

Journal Risk Manag Healthc Policy

Publisher Dove Medical Press

Specialty Public Health

Date 2022 May 23

PMID 35599752

Authors

Sharifah Saffinas Syed Soffian

Azmawati Mohammed Nawi

Rozita Hod

Mohd Rizal Abdul Manaf

Huan-Keat Chan

Muhammad Radzi Abu Hassan

Affiliations

Soon will be listed here.

Abstract

Regardless of the high global burden of colorectal cancer (CRC), the uptake of CRC screening varies across countries. This systematic review aimed to provide a picture of the disparities in recommendations for CRC screening in average-risk individuals using an ecobiosocial approach. It was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The literature search was conducted through Scopus, Web of Science, PubMed, and EBSCOHost. Full-text guidelines which were published between 2011 and 2021, along with guidelines which provided recommendations on CRC screening in average-risk individuals, were included in the review. However, guidelines focusing only on a single screening modality were excluded. Fourteen guidelines fulfilling the eligibility criteria were retained for the final review and analysis. Quality assessment of each guideline was performed using the AGREE II instrument. Disparities in guidelines identified in this review were classified into ecological (screening modalities and strategies), biological (recommended age, gender and ethnicities), and social (smoking history, socioeconomic status, and behavior) factors. In general, unstandardized practices in CRC screening for average-risk individuals are likely attributable to the inconsistent and non-specific recommendations in the literature. This review calls on stakeholders and policymakers to review the existing colorectal cancer screening practices and pursue standardization.

References

Senore C, Hassan C, Regge D, Pagano E, Iussich G, Correale L . Cost-effectiveness of colorectal cancer screening programmes using sigmoidoscopy and immunochemical faecal occult blood test. J Med Screen. 2018; 26(2):76-83. DOI: 10.1177/0969141318789710. View

Burgoine T, Sarkar C, Webster C, Monsivais P . Examining the interaction of fast-food outlet exposure and income on diet and obesity: evidence from 51,361 UK Biobank participants. Int J Behav Nutr Phys Act. 2018; 15(1):71. PMC: 6497220. DOI: 10.1186/s12966-018-0699-8. View

Gibson D, Prochaska J, Yu X, Kaul S . An examination between census tract unhealthy food availability and colorectal cancer incidence. Cancer Epidemiol. 2020; 67:101761. PMC: 8287297. DOI: 10.1016/j.canep.2020.101761. View

Alsanea N, Almadi M, Abduljabbar A, Alhomoud S, Alshaban T, Alsuhaibani A . National Guidelines for Colorectal Cancer Screening in Saudi Arabia with strength of recommendations and quality of evidence. Ann Saudi Med. 2015; 35(3):189-95. PMC: 6074460. DOI: 10.5144/0256-4947.2015.189. View

Stracci F, Zorzi M, Grazzini G . Colorectal cancer screening: tests, strategies, and perspectives. Front Public Health. 2014; 2:210. PMC: 4209818. DOI: 10.3389/fpubh.2014.00210. View

Rex D, Boland C, Dominitz J, Giardiello F, Johnson D, Kaltenbach T . Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017; 153(1):307-323. DOI: 10.1053/j.gastro.2017.05.013. View

Schreuders E, Ruco A, Rabeneck L, Schoen R, Sung J, Young G . Colorectal cancer screening: a global overview of existing programmes. Gut. 2015; 64(10):1637-49. DOI: 10.1136/gutjnl-2014-309086. View

Hultcrantz R . Aspects of colorectal cancer screening, methods, age and gender. J Intern Med. 2020; 289(4):493-507. PMC: 8048936. DOI: 10.1111/joim.13171. View

Millien V, Levine P, Gould Suarez M . Colorectal cancer screening in African Americans: are we following the guidelines?. Cancer Causes Control. 2021; 32(9):943-951. DOI: 10.1007/s10552-021-01448-8. View

10.

Quintero J, Pulido N, Logan J, Ant T, Bruce J, Carrasquilla G . Effectiveness of an intervention for Aedes aegypti control scaled-up under an inter-sectoral approach in a Colombian city hyper-endemic for dengue virus. PLoS One. 2020; 15(4):e0230486. PMC: 7112230. DOI: 10.1371/journal.pone.0230486. View

11.

Siegel R, Torre L, Soerjomataram I, Hayes R, Bray F, Weber T . Global patterns and trends in colorectal cancer incidence in young adults. Gut. 2019; 68(12):2179-2185. DOI: 10.1136/gutjnl-2019-319511. View

12.

Sung J, Ng S, Chan F, Chiu H, Kim H, Matsuda T . An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut. 2014; 64(1):121-32. DOI: 10.1136/gutjnl-2013-306503. View

13.

Bhatia D, Lega I, Wu W, Lipscombe L . Breast, cervical and colorectal cancer screening in adults with diabetes: a systematic review and meta-analysis. Diabetologia. 2019; 63(1):34-48. DOI: 10.1007/s00125-019-04995-7. View

14.

Mansori K, Mosavi-Jarrahi A, Motlagh A, Solaymani-Dodaran M, Salehi M, Delavari A . Exploring Spatial Patterns of Colorectal Cancer in Tehran City, Iran. Asian Pac J Cancer Prev. 2018; 19(4):1099-1104. PMC: 6031791. DOI: 10.22034/APJCP.2018.19.4.1099. View

15.

Yamashita H, Takahashi Y, Ishizaki T, Imura H, Nakayama T . Associations of multimorbidity with breast, cervical, and colorectal cancer screening delivery: a cross-sectional study of a nationally representative Japanese sample. Cancer Epidemiol. 2020; 69:101798. DOI: 10.1016/j.canep.2020.101798. View

16.

Johnson C, Wei C, Ensor J, Smolenski D, Amos C, Levin B . Meta-analyses of colorectal cancer risk factors. Cancer Causes Control. 2013; 24(6):1207-22. PMC: 4161278. DOI: 10.1007/s10552-013-0201-5. View

17.

Bryant J, Patterson K, Vaska M, Chiang B, Letendre A, Bill L . Cancer Screening Interventions in Indigenous Populations: A Rapid Review. Curr Oncol. 2021; 28(3):1728-1743. PMC: 8161813. DOI: 10.3390/curroncol28030161. View

18.

Lee S, OLeary M, Umble K, Wheeler S . Eliciting vulnerable patients' preferences regarding colorectal cancer screening: a systematic review. Patient Prefer Adherence. 2018; 12:2267-2282. PMC: 6216965. DOI: 10.2147/PPA.S156552. View

19.

Brouwers M, Kho M, Browman G, Burgers J, Cluzeau F, Feder G . AGREE II: advancing guideline development, reporting, and evaluation in health care. Prev Med. 2010; 51(5):421-4. DOI: 10.1016/j.ypmed.2010.08.005. View

20.

Naber S, Almadi M, Guyatt G, Xie F, Lansdorp-Vogelaar I . Cost-effectiveness analysis of colorectal cancer screening in a low incidence country: The case of Saudi Arabia. Saudi J Gastroenterol. 2021; 27(4):208-216. PMC: 8448011. DOI: 10.4103/sjg.sjg_526_20. View